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Abstract
Background: Campylobacter concisus is an emerging enteric pathogen, yet it is commonly isolated from feces and
the oral cavities of healthy individuals. This genetically complex species is comprised of several distinct
genomospecies which may vary in pathogenic potential.
Results: We compared pathogenic and genotypic properties of C. concisus fecal isolates from diarrheic and healthy
humans residing in the same geographic region. Analysis of amplified fragment length polymorphism (AFLP)
profiles delineated two main clusters. Isolates assigned to AFLP cluster 1 belonged to genomospecies A (based on
genomospecies-specific differences in the 23S rRNA gene) and were predominantly isolated from healthy
individuals. This cluster also contained a reference oral strain. Isolates assigned to this cluster induced greater
expression of epithelial IL-8 mRNA and more frequently contained genes coding for the zonnula occludins toxin
and the S-layer RTX. Furthermore, isolates from healthy individuals induced greater apoptotic DNA fragmentation
and increased metabolic activity than those from diarrheic individuals, and isolates assigned to genomospecies A
(of which the majority were from healthy individuals) exhibited higher haemolytic activity compared to
genomospecies B isolates. In contrast, AFLP cluster 2 was predominated by isolates belonging to genomospecies B
and those from diarrheic individuals. Isolates from this cluster displayed greater mean epithelial invasion and
translocation than cluster 1 isolates.
Conclusion: Two main genetically distinct clusters (i.e., genomospecies) were identified among C. concisus fecal
isolates from healthy and diarrheic individuals. Strains within these clusters differed with respect to clinical
presentation and pathogenic properties, supporting the hypothesis that pathogenic potential varies between
genomospecies. ALFP cluster 2 isolates were predominantly from diarrheic patients, and exhibited higher levels of
epithelial invasion and translocation, consistent with known roles for these factors in diarrhoeal disease. Conversely,
isolates from healthy humans and AFLP cluster 1 or genomospecies A (which were predominantly isolated from
healthy humans) exhibited increased haemolytic ability, apoptotic DNA fragmentation, IL-8 induction, and/or
carriage of toxin genes. Given that this cluster contains an oral reference strain, it is possible that some of the AFLP
cluster 1 isolates are periodontal pathogens and may cause disease, albeit via a different mechanism than those
from AFLP cluster 2.
Background
Campylobacter species are one of the most common
causes of human enteritis in North America (Centers
for Disease Control and Prevention, U.S. Department of
Agriculture, and Food and Drug Administration Colla-
borating Sites Foodborne Disease Active Survey
Network [FoodNet]; Public Health Agency of Canada
website, http://dsol-smed.phac-aspc.gc.ca/dsol-smed/
ndis/diseases/camp_e.html). While Campylobacter jejuni
and Campylobacter coli are the most commonly isolated
species, studies have also implicated ‘cryptic’ species
within the genus, such as Campylobacter concisus,a s
causal agents of acute enteritis [1-4]. Compared to
C. jejuni, C. concisus is fastidious to isolate as it is
often sensitive to selective antimicrobial agents
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generally requires a hydrogen-enriched atmosphere and
a prolonged incubation period for growth [5]. As such,
it is rarely cultured by standard isolation methods
employed by many diagnostic facilities. Although knowl-
edge of its clinical importance is limited, C. concisus has
been cited as an emerging human pathogen [5,6].
Campylobacter concisus was originally isolated from
periodontal lesions [7]. However, its pathogenic role in
oral cavity infections remains uncertain, since it can also
be isolated from healthy gingiva [8]. Additionally, C.
concisus has been isolated from the feces of diarrheic
patients [1-4], often in the absence of known pathogens.
However, the bacterium is also frequently isolated from
feces of asymptomatic patients, which has lead to the
conclusion that it may be part of the normal intestinal
microbiota [9,10]. Some evidence indicates that C. conci-
sus m a yb ea no p p o r t u n i s t i cp a t h o g e n .F o re x a m p l e ,
Engberg et al. [9] observed that C. concisus was predo-
minantly isolated from pediatric, elderly, and immuno-
compromised patients, in contrast to C. jejuni and C.
coli which are typically isolated from diarrheic patients
of all ages. Consequently because of its association with
diarrheic, healthy, and immunocompromised patients,
t h es p e c i f i cr o l eo fC. concisus as a primary intestinal
pathogen has yet to be firmly established.
Campylobacter concisus is a heterogeneous species
complex comprised of several phenotypically indistin-
guishable but genetically distinct taxa (“genomospecies”).
Numerous methods can be used to genetically separate
the genomospecies, including PCR analysis of the 23S
rRNA gene [11] and cluster analysis of amplified frag-
ment length polymorphism (AFLP) or random amplified
polymorphic DNA (RAPD) profiles [1,2]. Based on these
typing methods, at least two main C. concisus genomos-
pecies have been identified [1,2,4,11].
Differences in pathogenicity amongst distinct geno-
mospecies of some bacterial taxa [12,13] support the
notion that certain C. concisus genomospecies may be
more likely than others to cause intestinal disease.
While an early study by Van Etterijck et al. [10] con-
cluded that C. concisus was not pathogenic given similar
isolation rates from diarrheic and healthy children,
genetic diversity of the isolates with respect to clinical
presentation was not considered. A more recent study
showed that isolates from healthy individuals were
genetically distinct from those of diarrheal origin; how-
ever, differences in epithelial cytotoxicity between the
two groups were not evident [2]. Additionally, cluster
analysis of diarrheic isolate AFLP profiles delineated two
main C. concisus genomospecies (designated genomos-
pecies 1 and 2), which where characterized by type
strains of oral and diarrheal origin, respectively [1]. Gen-
omospecies 2 isolates were more frequently isolated
from the stool of patients presenting with diarrhea in
which no other pathogens were found, and bloody diar-
rhea was associated only with genomospecies 2 isolates.
While these studies suggest that distinct C. concisus
genomospecies may vary in their pathogenic ability, this
has yet to be empirically examined.
Our understanding of Campylobacter pathogenesis is
based primarily on C. jejuni. Its small, spiral shape
coupled with flagella-mediated motility, allow C. jejuni to
penetrate intestinal mucus [14] where it can then adhere
to and invade intestinal epithelial cells. This bacterium
can also translocate across the intestinal epithelium via a
paracellular mechanism involving disruption of epithelial
tight junctions [15,16] or via a lipid raft-mediated trans-
cellular mechanism [17]. C. jejuni also causes cellular
cytotoxicity through the production of various toxins;
cytolethal distending toxin (CDT) is a well-characterized
toxin produced by most strains. The cytolethal distending
toxin blocks cell proliferation in the G2/M phase result-
ing in cellular distension leading to the induction of
apoptotic cell dealth [18]. This bacterium also induces
intestinal epithelial secretion of interleukin-8 (IL-8), a
pro-inflammatory chemoattractant that recruits neutro-
phils to the site of infection [19]. Cytolethal distending
toxin-like activity has been reported for a majority of
clinical C. concisus isolates [2], however the role that this
toxin plays in pathogenesis is unknown. A membrane-
bound haemolytic phospholipase is also produced by
most clinical C. concisus isolates [20]. In addition, C. con-
cisus genes coding for zonnula occludins toxin (zot)a n d
a surface-layer protein belonging to the RTX (repeats in
the structural toxins) family (S-layer RTX) have been
recently identified [21]. Zonnula occludins toxin was first
recognized as a toxin of Vibrio cholera, and disrupts the
integrity of the intestinal epithelial barrier by targeting
tight junctions [22]. S-layer RTX is a pore-forming toxin
that is also found in Campylobacter rectus [23], and tox-
ins within this family are recognized as important viru-
lence factors [24].
The present study examines the hypothesis that the
two main C. concisus genomospecies exhibit differences
in pathogenicity. To address this hypothesis, we com-
pared genotypic and pathogenic properties of C. concisus
fecal isolates from diarrheic and asymptomatic
("healthy”) humans. Specifically, genotypes of isolates
were compared by AFLP analysis and a genomospecies-
specific 23S rRNA gene PCR assay. Numerous patho-
genic properties were also assessed including: (i) intest-
inal epithelial adherence, invasion, and translocation; (ii)
ability to disrupt epithelial permeability, cause apoptotic
DNA fragmentation, affect metabolic activity, and
induce IL-8; hemolytic and cytotoxic activities; and (iii)
carriage of toxin genes encoding CDT, ZOT, and S-
layer RTX proteins.
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Genotypes
Sequence analysis to confirm the identities of the
clinical isolates indicated >99% 16S rRNA gene
sequence similarity (near full-length) between the
type strain C. concisus L M G 7 7 8 8a n da l lo ft h ec l i n i -
cal isolates (GenBank accession numbers are listed in
Table 1). Based on the genomospecies-specific PCR
assay of the 23S rRNA gene [11], six and 12 of the 22
clinical C. concisus isolates were assigned to geno-
mospecies A and B, respective l y( T a b l e1 ) .T h r e ei s o -
lates generated PCR products for both genomospecies
A and B primer sets (designated “A/B”), and one iso-
late did not amplify with either primer set (designated
“X”). The type strain, LMG7788, was assigned to gen-
omospecies A, consistent with previous observations
[2]. Campylobacter concisus-specific PCR of the cpn60
gene was strongly positive for 21 isolates including
the type strain and weakly positive for two isolates.
Weak PCR products were likely due to mismatching
of the PCR primers with their target gene (due to
DNA sequence divergence), resulting in inefficient
PCR amplification.
AFLP analysis indicated considerable genetic variabil-
ity existed among the C. concisus isolates (Figure 1).
Reproducibility between duplicate independent analyses
of each isolate was 93.1 ± 3.6% (mean ± SD; Additional
file 1). The isolates clustered into two phylotypes distin-
guished from each other at the 34% similarity level. All
isolates assigned to AFLP cluster 1 belonged to geno-
mospecies A and included the type strain plus five iso-
lates that were obtained from healthy (n = 4) and
diarrheic (n = 1) humans. Of the seventeen isolates
assigned to AFLP cluster 2, 94% (16/17) were isolated
from diarrheic stools, and 71% belonged to genomospe-
cies B (n = 12) while 17% belonged to genomospecies
A/B (n = 3), 6% belonged to genomospecies A (n = 1),
and one isolate was unassigned.
Adherence, invasion, and translocation
All C. concisus isolates exhibited comparable epithelial
adherence to that of C. jejuni 81-176 (Table 2). The mean
adherence of isolates belonging to genomospecies A did
not differ from that of isolates belonging to genomospecies
B( 6 . 0 0±0 . 0 8l o g 10 CFU/ml, n = 6 versus 6.28 ± 0.20 log10
CFU/ml, n = 5, respectively; P = 0.20). Similarly, mean
Table 1 Campylobacter concisus isolates
Isolate Source Genomospecies
a cpn60
b GenBank
c Accession #
CHRB6 Feces, diarrheic human B + HM_536958.0
CHRB39 Feces, diarrheic human A/B + n/a
CHRB318 Feces, diarrheic human B + HM_536953.0
CHRB563 Feces, diarrheic human A/B + HM_536957.0
CHRB1462 Feces, diarrheic human B + HM_536942.0
CHRB1569 Feces, diarrheic human B + HM_536943.0
CHRB1609 Feces, diarrheic human A + HM_536944.0
CHRB1656 Feces, diarrheic human B + HM_536945.0
CHRB1794 Feces, diarrheic human A/B + HM_536946.0
CHRB2004 Feces, healthy human A + HM_536947.0
CHRB2011 Feces, healthy human A + HM_536948.0
CHRB2050 Feces, diarrheic human A + HM_536949.0
CHRB2167 Feces, diarrheic human B + n/a
CHRB2370 Feces, diarrheic human B + HM_536950.0
CHRB2691 Feces, diarrheic human B + HM_536951.0
CHRB2880 Feces, diarrheic human B + n/a
CHRB3152 Feces, diarrheic human B W HM_536952.0
CHRB3235 Feces, healthy human X W HM_536954.0
CHRB3287 Feces, healthy human A + HM_536955.0
CHRB3290 Feces, healthy human A + HM_536956.0
CHRB3559 Feces, diarrheic human B + n/a
CHRB3612 Feces, diarrheic human B + n/a
LMG7788 Type strain, gingival sulcus A + DQ_174166.1
aGenomospecies determined using PCR assay for C. concisus 23S rRNA gene. A/B indicates amplification with primer sets for both genomotype A and B. ×
indicates lack of PCR amplification with either primer set.
b+ indicates PCR amplification of cpn60 gene; w indicates weak PCR amplification.
cNear full-length 16S rRNA gene sequence.
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individuals and isolates from healthy volunteers (6.25 ±
0.11 log10 CFU/ml, n = 9 versus 6.08 ± 0.14 log10 CFU/ml,
n = 5, respectively; P = 0.35), nor was it different for iso-
lates assigned to AFLP cluster 1 versus cluster 2 (5.00 ±
0.09 log10 CFU/ml, n = 5 versus 6.30 ± 0.11 log10 CFU/ml,
n = 9, respectively; P = 0.09).
Epithelial invasion for seven C. concisus isolates was
equivalent to that of C. jejuni 81-176, including one of
five isolates from AFLP cluster 1 and six of nine isolates
for AFLP cluster 2 (Table 2). Isolates from AFLP cluster
2w e r em o r ei n v a s i v et h a nc l u ster 1 isolates (5.02 ± 0.16
log10 CFU/ml versus 4.27 ± 0.30 log10 CFU/ml, respec-
tively; P = 0.03). Mean invasion did not differ between
isolates from diarrheic and healthy humans (4.88 ± 0.15
log10 CFU/ml versus 4.52 ± 0.41 log10 CFU/ml, respe-
cively; P = 0.33) or isolates belonging to genomospecies
A and B (4.34 ± 0.25 log10 CFU/ml versus 5.06 ± 0.24
log10 CFU/ml, respectively; P = 0.07). Adherence and
invasion were positively correlated (R
2 = 0.71; P < 0.001).
Epithelial translocation was not different for any of the
C. concisus isolates relative to C. jejuni 81-176 (Table 2).
The mean translocation of C. concisus genomospecies B
isolates was greater than isolates belonging to genomos-
pecies A (4.46 ± 0.20 log10 CFU/ml versus 3.99 ± 0.09
log10 CFU/ml, respectively; P = 0.048), and isolates
assigned to AFLP cluster 2 relative to cluster 1 (4.58 ±
0.16 log10 CFU/ml versus 3.99 ± 0.11 log10 CFU/ml,
respectively; P = 0.03). Mean translocation between iso-
lates from diarrheic and healthy humans did not differ
(4.48 ± 0.15 log10 CFU/ml versus 4.17 ± 0.25 log10
CFU/ml, respecively; P = 0.26). Translocation and inva-
sion were weakly correlated (R
2 =0 . 2 7 ;P =0 . 0 5 9 ) .
There were no differences in the initial or final TER
between Campylobacter-treated monolayers and the
sterile broth control, and the final TER of all mono-
layers remained greater than 1000 Ω ×c m
2 (Additional
file 2) indicating that translocation occurred across an
intact epithelial barrier. Also, FITC-dextran permeability
did not differ for monolayers treated with C. concisus
relative to the sterile broth control (Additional file 2).
Hemolysis, DNA fragmentation, cytotoxicity, and
metabolic activity
All Campylobacter isolates exhibited hemolytic activity
as defined by the percent lysis of sheep red blood cells
Figure 1 Dendrogram of AFLP profiles derived using the unweighted-pair group average linkage of Pearson-product-moment
correlation coefficients from 22 Campylobacter concisus fecal isolates (designated CHRB) and the type strain (LMG7788). The bar
indicates percentage similarity. LMG, Culture Collection of the Laboratorium voor Microbiologie, Gent, Belgium. H, healthy humans. D, diarrheic
humans. T, type strain. GS, genomospecies as determined by PCR assay of the 23S rRNA gene (2). A, genomospecies A. B, genomospecies B. A/B,
indicates positive PCR for both genomospecies A and B. X, indicates negative PCR for both genomospecies A and B. cpn, C. concisus-specific
cpn60 PCR. +, positive PCR. W, weak positive PCR. -, negative PCR.
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Mean hemolysis for genomospecies A isolates was
greater than for isolates belonging to genomospecies B
(64.0 ± 4.9% and 45.2 ± 5.1%, respectively; P =0 . 0 2 7 ) .
Mean hemolysis did not differ between isolates from
healthy and diarrheic individuals (55.9 ± 8.2% versus
52.0 ± 5.2%, respectively; P = 0.68), nor between isolates
assigned to AFLP clusters 1 and 2 (63.9 ± 6.0% versus
47.5 ± 5.0%, respectively; P = 0.06). There was an
inverse correlation between hemolysis and invasion (R
2
=0 . 7 4 ;P < 0.0001) and between hemolysis and adher-
ence (R
2 = 0.43; P < 0.011). None of the C. concisus iso-
lates caused significant epithelial cytotoxicity, whereas
Campylobacter jejuni 81-176 and H2O2 induced cyto-
toxicity in agreement with previous observations [25]
(Table 3).
Epithelial DNA fragmentation was significantly
induced by all five C. concisus isolates from healthy indi-
viduals, 44.4% of the isolates from diarrheic humans
(i.e., four of nine isolates), C. concisus LMG7788, C.
jejuni 81-176, and the apoptosis-inducing agent, camp-
tothecin (Table 3). Greater mean DNA fragmentation
was observed for isolates from healthy volunteers com-
pared to diarrheic individuals (1.78 ± 0.05 A370 nm ver-
sus 1.48 ± 0.08 A370 nm, respectively; P = 0.021). There
was no difference in DNA fragmentation between iso-
lates belonging to genomospecies A and B (1.66 ± 0.10
A370 nm versus 1.54 ± 0.13 A370 nm, respecively; P =
0.45), nor between isolates in AFLP groups 1 and 2
(1.72 ± 0.10 versus 1.52 ± 0.08 A370 nm, respectively; P
= 0.15).
Epithelial cells inoculated with isolates from AFLP
cluster 1 exhibited higher metabolic activity (i.e., MTT
value) than those inoculated with AFLP cluster 2 iso-
lates (147.7 ± 2.8 versus 134.6 ± 4.0%, respectively; P =
0.04). Likewise, metabolic activity in epithelial cells
inoculated with isolates from healthy individuals was
higher than that for isolates from diarrheic individuals
(147.4 ± 2.9% versus 134.7 ± 4.0%, respectively; P =
0.049). Mean metabolic activity did not differ between
isolates from genomospecies A and B (144.9 ± 3.6% ver-
sus 132.3 ± 7.0%, respectively; P = 0.13). Metabolic
activity was positively correlated with DNA fragmenta-
tion (R
2 = 0.47; P = 0.007).
Expression of IL-8
All C. concisus isolates and C. jejuni 81-176 increased
the expression of epithelial IL-8 mRNA more than two-
fold (Table 4). In contrast, IL-8 mRNA expression in
monolayers treated with non-pathogenic E. coli HB101
(0.94 ± 0.17 fold) was similar to that of the sterile broth
control (assigned a value of 1). IL-8 mRNA expression
was higher in epithelial cells treated with isolates from
AFLP cluster 1 compared to cells treated with AFLP
cluster 2 isolates (5.03 ± 0.49 fold versus 3.80 ± 0.30
fold, respectively; P = 0.04). Mean IL-8 expression did
not differ between C. concisus isolates belonging to gen-
omospecies A and B (4.63 ± 0.57 fold versus 4.27 ± 0.35
fold, respectively; P = 0.62), nor between isolates from
healthy and diarrheic humans (4.44 ± 0.72 fold versus
4.12 ± 0.29 fold, respectively; P = 0.64). Interleukin-8
expression was not correlated with invasion (R
2 = 0.002;
P = 0.87) or translocation (R
2 = 0.14; P = 0.19).
Toxin genes
The CDT B gene was not detected in any of the C. con-
cisus isolates, but was present in C. jejuni 81-176 (Addi-
tional file 3). The zot gene was detected in 80% of C.
concisus isolates from healthy humans (i.e., four of five
isolates), 22% of isolates from diarrheic humans (i.e.,
two of nine isolates), and the type strain. The S-layer
RTX gene was present in C. concisus CHRB3287 and
CHRB2004, although amplification was weak for the lat-
ter isolate. The zot and S-layer RTX genes were not
detected in C. jejuni 81-176.
Discussion
The observed high level of genetic diversity amongst the
isolates of C. concisus is in agreement with previous stu-
dies [1,2,10], and highlights the complex nature of this
species. Cluster analysis of AFLP profiles indicated that
Table 2 Intestinal epithelial adherence, invasion, and
translocation of Campylobacter concisus isolates
a
Isolate AFLP
cluster
Adherence
(log10
CFU/ml)
Invasion
(log10
CFU/ml)
Translocation
(log10
CFU/ml)
CHRB2004 1 6.12 ± 0.30
b 4.50 ± 0.19 4.31 ± 0.65
b
CHRB3287 1 6.03 ± 0.28
b 4.72 ± 0.11
b 3.74 ± 0.18
b
CHRB2011 1 6.11 ± 0.21
b 4.62 ± 0.18 3.87 ± 0.31
b
CHRB3290 1 5.63 ± 0.31
b 3.09 ± 0.10 3.84 ± 0.22
b
CHRB1609 1 6.06 ± 0.06
b 4.44 ± 0.12 4.19 ± 0.40
b
CHRB1794 2 6.30 ± 0.26
b 4.53 ± 0.13 5.07 ± 0.82
b
CHRB6 2 6.03 ± 0.03
b 5.06 ± 0.22
b 4.38 ± 0.96
b
CHRB1569 2 5.82 ± 0.14
b 4.60 ± 0.23 3.71 ± 0.16
b
CHRB2691 2 6.13 ± 0.24
b 4.55 ± 0.21 4.86 ± 0.63
b
CHRB2370 2 6.43 ± 0.20
b 5.25 ± 0.13
b 4.74 ± 0.45
b
CHRB2050 2 6.06 ± 0.06
b 4.64 ± 0.11
b 3.97 ± 0.44
b
CHRB563 2 6.48 ± 0.39
b 5.01 ± 0.18
b 4.77 ± 0.45
b
CHRB3152 2 6.97 ± 0.03
b 5.86 ± 0.34
b 4.64 ± 0.54
b
CHRB3235 2 6.48 ± 0.26
b 5.65 ± 0.40
b 5.07 ± 0.28
b
LMG7788 1 5.16 ± 0.29
b 3.26 ± 0.19 4.00 ± 0.31
b
C. jejuni 81-
176
– 6.26 ± 0.34 5.70 ± 0.12 5.41 ± 0.49
aData are means ± SEM, n = 3.
bNot significantly different from C. jejuni 81-176 (P > 0.05).
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least two distinct clusters. Similarly, Aabenhus et al. [1]
denoted four AFLP clusters among 62 C. concisus iso-
lates of which the majority (n = 56) were assigned to
one of two main clusters. Results of PCR assays target-
ing the 23S rRNA and cpn60 genes largely corresponded
with the AFLP grouping, and lend support to the sug-
gested genetic relationship between the isolates.
As C. concisus is a common inhabitant of the oral cav-
ity, it is to be expected that it may be isolated from both
healthy and diarrheic individuals. Examining isolates
from healthy individuals, it was observed that the major-
ity of isolates belonged to genomospecies A and their
AFLP profiles clustered together (AFLP cluster 1) along
with the type stain of oral origin. This AFLP cluster also
included one genomospecies A isolate (CHRB 1609)
from a diarrheic individual. Further studies are needed
to determine whether this group of isolates represents
inhabitants of the oral cavity that have survived gastro-
intestinal transit or whether they are intestinal-
associated.
The majority (94%) of isolates from diarrheic indivi-
duals were assigned to ALFP cluster 2. Among these
isolates, 71% were assigned to genomospecies B, while
only 11% of diarrheic isolates belonged to genomospe-
cies A. Engberg et al. [2] reported a similar predomi-
nance of genomospecies B isolates among diarrheic fecal
isolates, of which 33% and 67% were assigned to geno-
mospecies A and B, respectively. Likewise, Aabenhus
et al. [1] reported that 34% and 53% of fecal isolates
from diarrheic patients were assigned to genomospecies
A and B, respectively. Our observation that isolates
from genomospecies B were exclusively obtained from
diarrheic individuals suggests a potential role for these
isolates in intestinal disease. A comparative molecular
examination of strains belonging to genomospecies A
and B may shed light on their respective pathogenic
potential.
Examination of the pathogenic properties amongst C.
concisus isolates determined that epithelial invasion and
translocation were higher for isolates assigned to AFLP
cluster 2 (of which 94% were from diarrheic individuals).
Additionally, epithelial translocation was higher for iso-
lates belonging to genomospecies B (of which all isolates
were from diarrheic individuals). This is of potential
clinical relevance as invasiveness and translocation
Table 3 Hemolysis, DNA fragmentation, cytotoxicity, and metabolic activity of Campylobacter concisus isolates
a
Isolate AFLP
Cluster
Hemolysis
b
(%)
DNA fragmentation
c
(A370 nm)
Cytotoxicity
c
(%)
Metabolic activity
c
(% control)
CHRB2004 1 60.2 ± 14.4 1.84 ± 0.17
d 1.23 ± 0.21 139.4 ± 7.4
CHRB3287 1 45.6 ± 16.9 1.83 ± 0.13
d 1.48 ± 0.16 146.8 ± 9.2
CHRB2011 1 60.5 ± 9.8 1.63 ±.0.05
d 0.88 ± 0.22 151.9 ± 7.5
CHRB3290 1 81.1 ± 4.5 1.91 ± 0.14
d 0.94 ± 0.19 155.7 ± 2.3
CHRB1609 1 72.3 ± 9.4 1.37 ± 0.18 1.11 ± 0.34 144.5 ± 4.4
CHRB1794 2 70.9 ± 10.1 1.32 ± 0.19 1.42 ± 0.15 137.9 ± 2.9
CHRB6 2 41.2 ± 11.6 1.12 ± 0.26 1.43 ± 0.18 105.1 ± 26.2
e
CHRB1569 2 47.0 ± 12.0 1.38 ± 0.17 1.29 ± 0.26 139.2 ± 7.0
CHRB2691 2 62.1 ± 14.3 1.62 ± 0.07
d 1.89 ± 0.15 133.5 ± 10.3
CHRB2370 2 44.9 ± 12.0 1.69 ± 0.14
d 1.46 ± 0.08 142.8 ± 6.5
CHRB2050 2 64.3 ± 15.4 1.41 ± 0.07 0.97 ± 0.15 131.0 ± 7.1
CHRB563 2 34.6 ± 13.9 1.55 ± 0.23
d 1.25 ± 0.20 138.0 ± 10.2
CHRB3152 2 30.7 ± 15.4 1.89 ± 0.16
d 1.28 ± 0.15 141.0 ± 6.0
CHRB3235 2 32.1 ± 18.6 1.69 ± 0.12
d 1.14 ± 0.16 143.2 ± 6.3
LMG7788 1 61.5 ± 10.8 1.54 ± 0.08
d 0.71 ± 0.10 140.8 ± 5.2
C. jejuni 81-176 – 75.6 ± 3.7 1.68 ± 0.25
d 4.53 ± 0.31
d 143.7 ± 5.7
Broth control – 0.44 ± 0.14 0.69 ± 0.12 0.96 ± 0.34 100
H2O2 –– 1.38 ± 0.22 6.15 ± 1.66
d 259.5 ± 13.5
Camptothecin –– 2.23 ± 0.40
d 1.39 ± 0.28 177.5 ± 9.2
aData are means ± SEM, n = 3.
bPercent total hemolysis of sheep erythrocytes for 1/8 dilution of Campylobacter inoculum.
cAssays conducted using T84 monolayers.
dP < 0.05 relative to the broth control treatment.
eSloughing of epithelial cells noted in two of three repetitions.
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enteritis in C. jejuni-infected patients [26] and are likely
associated with inflammatory responses and occasional
bacteraemia observed with C. concisus infections [27].
To our knowledge, this is the first study to report differ-
ences in pathogenicity between the two main C. concisus
genomospecies, further supporting the likelihood that
isolates belonging to AFLP cluster 2/genomospecies B
incite enteritis in humans.
All of the clinical C. concisus isolates examined in the
current study caused hemolysis of sheep erythrocytes,
consistent with previous observations of hemolytic phos-
pholipase activity in all C. concisus genomospecies A
and B isolates from diarrheic children [20]. As such,
hemolytic activity appears to be a general characteristic
of this species. Hemolysins are involved in pathogenesis
and host colonization in other taxa [28], thus it was an
unexpected observation that C. concisus genomospecies
A isolates exhibited greater mean hemolysis than iso-
lates belonging to genomospecies B. We also observed
that hemolytic activity by C. concisus was inversely cor-
related with epithelial adherence and invasion. Staphylo-
coccus aureus exhibits a similar inverse correlation that
is attributed to interference of its a-hemolysin with
epithelial b1-integrins that mediate host-cell interactions
[29]. Moreover, lower amounts of a-hemolysin are
produced by invasive S. aureus isolates from endocardi-
tis patients compared to less-invasive isolates from open
wounds [30]. Whether C. concisus hemolysin also inter-
feres with epithelial receptors that promote adherence
and invasion is unknown, and additional studies are
warranted.
Another unexpected finding was that isolates from
healthy individuals induced greater mean epithelial DNA
fragmentation and metabolic activity compared to those
from diarrheic individuals, and these variables were posi-
tively correlated. DNA fragmentation is used as an indica-
tor of cell death. The two primary modes of cell death,
namely apoptosis and necrosis, can be distinguished on
the basis of physiologic features. DNA fragmentation can
be present in both processes; however, during apoptosis,
cell membranes typically remain intact, whereas during
necrosis, cellular integrity is rapidly disrupted leading to
the release of cytoplasmic contents (including lactate
dehydrogenase) into the surrounding environment ("cyto-
toxicity”). Based on this definition, four isolates from
healthy individuals (CHRB2004, CHRB3235, CHRB3287,
and CHRB3290) and two isolates from diarrheic humans
(CHRB2370 and CHRB3152) induced cell death consistent
with apoptosis. While apoptosis can be mediated via CDT
[18], it is unlikely that CDT was involved in the apoptosis
given that we did not detect the CDTB gene in any of the
strains included in our study. Furthermore, we did not
find any genes with similar sequence to the CDTB gene
using a BLAST search of the published C. concisus gen-
ome (NCBI accession number NC_009802), indicating
that other factors (i.e. opposed to the CDT) may be
responsible. The role that Campylobacter-induced epithe-
lial cell death plays in pathogenesis is currently poorly
understood; hence, the clinical significance of these find-
ings for C. concisus remains to be determined.
Metabolic activity can be measured using the MTT
assay in which metabolically active epithelial cells reduce
a yellow tetrazolium salt (MTT) to purple formazan
crystals that can be spectrophotometrically quantified.
All of the isolates that we examined, except one isolate
that caused epithelial sloughing (CHRB6), induced
higher MTT values (> 130%) than the control, indicating
that epithelial metabolic activity is increased by C. conci-
sus. Some clinical strains of C. jejuni have also been
reported to cause similar increases in epithelial MTT
values [31]. Given the short incubation period for the
MTT assay, we conclude that the increased values most
likely reflect an increase in metabolic activity due to cel-
l u l a rs t r e s sr a t h e rt h a na ni n c r e a s ei ne p i t h e l i a lc e l l
numbers due to proliferation. The observed correlation
between metabolic activity and DNA fragmentation may
be a consequence of the increased energy demands
required to sustain the apoptotic process (i.e., apoptotic
DNA fragmentation is an ATP-dependent process [32]).
Table 4 Expression of interleukin 8 mRNA in T84
monolayers inoculated with Campylobacter concisus
isolates
a
Isolate AFLP
cluster
IL-8 mRNA expression
(fold induction
b)
CHRB2004 1 4.65 ± 1.82
CHRB3287 1 6.13 ± 1.14
CHRB2011 1 5.76 ± 1.16
CHRB3290 1 3.35 ± 0.63
CHRB1609 1 5.28 ± 1.77
CHRB1794 2 3.92 ± 0.91
CHRB6 2 4.53 ± 0.89
CHRB1569 2 4.11 ± 0.93
CHRB2691 2 3.49 ± 1.51
CHRB2370 2 5.46 ± 1.67
CHRB2050 2 2.61 ± 1.01
CHRB563 2 3.92 ± 2.51
CHRB3152 2 3.75 ± 0.42
CHRB3235 2 2.30 ± 0.25
LMG7788 1 4.53 ± 0.81
C. jejuni 81-176 – 6.55 ± 1.35
E. coli HB101 – 0.94 ± 0.17
aData are means ± SEM, n = 3.
bExpression of IL-8 relative to basal level of expression (assigned a value of 1).
Data were normalized using the housekeeping gene C1orf33f.
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tion. In the current study, all C. concisus isolates
induced transcription of IL-8 in epithelial monolayers (>
2-fold) as has been previously reported for C. jejuni [19]
and C. concisus [33]. Campylobacter jejuni induces
epithelial IL-8 secretion by at least two independent
mechanisms, one of which requires invasion and the
other that is CDT-dependent [19,34]. We observed that
induction of IL-8 transcription by C. concisus was not
correlated with invasion. Man et al. also recently showed
that three C. concisus strains stimulated production of
IL-8 in intestinal epithelial irrespective of their invasive
ability [33]. Thus in contrast to C. jejuni, it appears that
factors other than invasion or CDT (which appears to
be lacking in this species) are responsible for the up-reg-
u l a t i o no fI L - 8i n c i t e db yC. concisus. The observation
that expression of IL-8 mRNA was greater in epithelial
cells treated with isolates from AFLP cluster 1 compared
to isolates from cluster 2 was unexpected and suggests
that these isolates may have pathogenic potential.
We identified genes encoding S-layer RTX and the
zonnula occludins toxin in some of the isolates, con-
firming initial reports of these toxin genes in C. concisus
[21]. Surprisingly, the zot gene was more prevalent in
isolates from healthy (80%) compared to diarrheic (22%)
humans. The clinical significance of this observation
remains to be determined. Although Zot has been
shown to disrupt epithelial tight junctions, we did not
observe any changes in permeability or TER of epithelial
monolayers throughout the 3 h incubation period for
any of the isolates. This is contrary to the observation of
Man et al., that C. concisus caused increased epithelial
permeability, decreased TER, and loss of membrane-
associated zonnula occludens and occludin in epithelial
monolayers [33]. Possible reasons for this discrepancy
include variation in methodology between the two stu-
dies (i.e., Man et al. inoculated Caco-2 cells with an
MOI of 200, and assessed barrier function 6 h-post
inoculation.).
Conclusion
In summary, two main genomospecies were identified
among fecal isolates of C. concisus from healthy and
diarrheic individuals. The genomospecies differed with
respect to clinical presentation and pathogenic proper-
ties, which is consistent with the hypothesis that certain
genomospecies have different pathogenic potential.
AFLP cluster 2 was predominated by isolates belonging
to genomospecies B and those from diarrheic indivi-
duals. Isolates from this cluster displayed higher mean
epithelial invasion and translocation than cluster 1 iso-
lates, consistent with a potential role in inflammatory
diarrhea and occasional bacteraemia. In contrast, isolates
assigned to AFLP cluster 1 belonged to genomospecies
A and were predominantly (but not strictly) isolated
from healthy individuals. Isolates assigned to this cluster
induced greater expression of epithelial IL-8 mRNA and
more frequently contained genes coding for the zonnula
occludins toxin and the S-layer RTX. Furthermore, iso-
lates from healthy individuals induced greater apoptotic
DNA fragmentation and increased metabolic activity
than did isolates from diarrheic individuals, and isolates
assigned to genomospecies A (of which the majority
were from healthy individuals) exhibited higher haemo-
lytic activity compared to genomospecies B isolates.
This suggests that isolates from this cluster may also
cause disease, albeit via different mechanisms than iso-
lates from AFLP cluster 2. AFLP cluster 1 contains a
reference strain isolated from the oral cavity, thus it is
possible that this cluster contains isolates that are pri-
marily periodontal pathogens.
While in vitro pathogenicity assessments are informa-
tive, they do not necessarily correspond with the ability
of an isolate to cause disease in vivo. Clearly, further
studies, particularly in vivo, are needed to confirm that
these genetically distinct groups of C. concisus indeed
differ in their ability to cause intestinal disease. In this
regard, comparative genomic and pathogenicity exami-
nations using animal models have been initiated.
Methods
Bacterial isolates and growth conditions
At o t a lo f2 3C. concisus isolates recovered from differ-
ent individuals were used in this study (Table 1). These
included five isolates recovered from the stools of
healthy volunteers (i.e., individuals that exhibited no
recent symptoms of enteritis), 17 isolates obtained from
stools of diarrheic humans, and the type strain of C.
concisus isolated from the oral cavity of a healthy
human (LMG7788; = CCUG 13144; = ATCC 33237).
Isolates were collected from people residing in the Chi-
nook Health Region of Southwestern Alberta, Canada.
These isolates were originally collected as part of a lar-
ger study [35]. Scientific and ethics approval for stool
collection was obtained from the Regional Ethics Com-
mittee of the former CHR and from the University of
Lethbridge Human Subject Research Committee. Cam-
pylobacter jejuni 81-167 [36] was used as a positive
pathogen control for all pathogenicity assays. In addi-
tion, the non-pathogenic Escherichia coli HB101 was
used as a negative pathogen control for measuring
epithelial IL-8 expression in response to the presence of
bacteria. Isolates were stored at -80°C in Columbia
broth (Difco, Detroit, MI) containing 40% glycerol. With
the excepiton of E. coli w h i c hw a sg r o w ni na na e r o b i c
enviornment, inocula of C. concisus for cell culture
assays were prepared by growing isolates for 14-16 h in
Columbia broth (37°C, 100 rpm) in a microaerobic
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balance nitrogen).
16S rRNA gene sequence
Genomic DNA was extracted using a DNAeasy Tissue
kit (Qiagen Inc., Mississauga, ON) according to the
manufacture’s instructions. The 16S rRNA gene was
PCR amplified using the primers UNI27F and
UNI1492R [37] (Table 5) and the resultant product was
used as template for sequencing. A BigDye Terminator
kit (Applied Biosystems, Foster City, CA) along with
universal primers (Table 5) were used for sequencing
the near full-length 16s rRNA gene according to the
manufacturer’s instructions. Sequence reactions were
separated with an ABI 3130 automated DNA sequencer
(Applied Biosystems). Sequences were analyzed using
Sequencher software (Gene Codes, Ann Arbor, MI) and
compared directly with the NCBI non-redundant
nucleotide database using BLASTN.
Amplified fragment length polymorphism analysis
Campylobacter concisus isolates were genotyped using
the AFLP protocol described by Kokotovic and On [38].
Briefly, genomic DNA (125 ng) was digested with Cps6I
(10 U) in Y+/Tango Buffer (MBI) for 1 h at 37°C. BglII
(10 U) was then added, and digestion was continued for
one additional hour. Restriction site-specific adaptors
(Table 5) were then ligated to the digested fragments
for 2 h at room temperature. PCR amplification of the
ligation mixture (diluted 10-fold) was carried out using
primers BGL2F-0 and CSP6I-A (Table 5) for 35 cycles
with an annealing temperature of 54°C. The final pro-
ducts were separated with an ABI 3130 automated DNA
sequencer (Applied Biosystems). To analyze AFLP pro-
files, fragments ranging from 75 to 500 bp and the
500LIZ Genescan molecular mass standard were
imported and compared using the BioNumerics 4.01
software (Applied Maths, Kortrijk, Belgium). Relation-
ship of AFLP profiles ("curves”)w e r ei n f e r r e db yu s eo f
the Pearson-product-moment correlation coefficient
(applying 2% optimizatio n )a n dc l u s t e r e db yt h e
unweighted pair group with mathematical average
(UPGMA) method. To ensure reproducibility, AFLP
analysis was conducted twice for isolate, and one repre-
sentative of each AFLP profile was used for cluster
analysis.
PCR for 23S rRNA, cpn60, CDT B, S-layer RTX, and zot
genes
Primers for PCR are listed in Table 5. PCR amplification
of the 23S rRNA gene was conducted according to the
method of Bastyns et al. [11], except that the two
reverse primers (CON1 and CON2) were used indepen-
dently rather than as a mixture. Isolates amplifying with
either MUC1/CON1 or MUC1/CON2 primers were
assigned to genomospecies A or B, respectively. Campy-
lobacter concisus-specific nested-PCR amplification of
t h ec h a p e r o n i ng e n e( cpn60) was conducted using the
primers Ccon-cpn_66f and Ccon_cpn_423r for 25 cycles
with an annealing temperature of 53°C [35]. The resul-
tant PCR product was used as a template for a second
round of PCR with the nested primers Ccon_cpn_72f
and Ccon_cpn_342r for 30 cycles with an annealing
temperature of 53°C. PCR for the CDT B gene was con-
ducted using the primers P5 and P6 (Table 5) for 30
cycles with an annealing temperature of 65°C. PCR for
the S-layer RTX gene was conducted using the primers
FCCC13826_1838 and RFCCC13826_1838 (Table 5) for
30 cycles with an annealing temperature of 58°C. PCR
for the zot gene was conducted using the primers
FCCC13826_2075 and RFCCC13826_2075 for 30 cycles
with an annealing temperature of 56°C.
Intestinal epithelial cell culture and inoculation
T84 human colonic epithelial cells (passages 7 to 20;
ATCC, Manassas, VA) were grown in DMEM/Ham F-
12 plus 10% fetal bovine serum, 200 mM L-glutamine,
100 U/ml penicillin, 100 μg/ml streptomycin, 80 μg/ml
tylosin (all from Sigma, Oakville, ON), and incubated at
37°C and 5% CO2. For cell culture assays, confluent T84
monolayers were washed twice and media was replaced
with antibiotic-free DMEM/Ham F12. Monolayers were
inoculated with sterile Columbia broth (= control) or
Campylobacter to achieve a multiplicity of infection of
100 CFU per epithelial cell, and incubated for 3 h at 37°
C. Due to the intensive nature of the assays for assess-
ment of pathogenic potential (i.e., adherence, invasion,
translocation, hemolytic ability, and cytotoxicity), repre-
sentative isolates of C. concisus from diarrheic and
healthy humans were examined for pathogenicity (n = 5
from AFLP cluster 1, n = 9 from AFLP cluster 2).
Adherence and invasion
T84 enterocyte monolayers were grown in 24-well plates
and inoculated as described above. Following incubation,
monolayers were washed three times with PBS. To
assess adherence, monolayers were lysed with 0.1% Tri-
ton X-100 in PBS for 10 min at room temperature on
an orbital shaker. Following lysis, bacteria were enumer-
ated by plating ten-fold serial dilutions onto Karmali
agar (Oxoid, Nepean, ON). Invasion was determined
using a gentamicin protection assay. After incubation,
monolayers were washed three times with PBS. Mono-
layers were then incubated for 2 h with fresh tissue cul-
ture medium containing gentamicin (500 μg/ml) to kill
extracellular bacteria as previously described [39]. Fol-
lowing incubation, monolayers were washed, lysed and
bacteria were enumerated as for the adherence assay.
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a bactericidal concentration of gentamicin was used for
the invasion assay.
Translocation and epithelial permeability
T84 cells were seeded onto Transwell filters at 4 × 10
5
cells/filter (5 μm pore size, 1.13 cm
2;C o s t a r ,C o r n i n g
Inc. Corning, NY) and cultured as described above.
Transepithelial electrical resistance (TER) was moni-
tored with an electrovoltohmeter (World Precision
Instruments, Sarasota, FL), and monolayers were used at
confluence (TER >1000 Ω ×c m
2). Monolayers were
inoculated as described above. Following incubation, the
basolateral medium was serially diluted, spread onto
Table 5 Primers and adaptors used in this study
Target
a Primer/Adaptor Sequence (5’ to 3’) Size (bp) Reference
– Bgl II adaptor1 CGGACTAGAGTACACTGTC – [38]
– Bgl II adaptor2 GATCGACAGTGTACTCTAGTC – [38]
– Csp6 I adaptor1 AATTCCAAGAGCTCTCCAGTAC – [38]
– Csp6 I adaptor2 TAGTACTGGAGAGCTCTTGG – [38]
– BLG2F-0 6-fam-GAGTACACTGTCGATCT – [38]
– CSP61-A GAGCTCTCCAGTACTACA – [38]
Universal 16S rRNA gene UNI27F AGAGTTTGATCCTGGCTCAG – [37]
UNI338F ACTCCTACGGGAGGCAG – [37]
UNI1100R AGGGTTGCGCTCGTTG – [37]
UNI1492R TACGG(C/T)TACCTTGTTACGACT – [37]
C. concisus 23S rRNA gene MUC1 (forward) ATGAGTAGCGATAATTGGG – [11]
CON1 (reverse) CAGTATCGGCAATTCGCT 306 [11]
CON2 (reverse) GACAGTATCAAGGATTTACG 308 [11]
C. concisus cpn gene
(primary primers)
Ccon-cpn_66f TATCGAAGTGAAACGTGGCA 357 [35]
Ccon_cpn_423r GCTCAAGCACTGGCAATAAG – [35]
C. concisus cpn gene
(nested primers)
Ccon_cpn_72f AGTGAAACGTGGCATGGATA 270 [35]
Ccon_cpn_342r GCATCTTTTCAGGGTTTGTG – [35]
C. concisus S-layer RTX gene
(YP_001465940.1)
FCCC13826_1838 ACAGGCCATAAGTGGATTGC 374 This study
RCCC13826_1838 CCGTCATAGTGGGCTCTCAT – This study
C. concisus zot gene
(YP_001467422)
FCCC13826_2075 TGCAAACCCTTTGTGATGAA 355 This study
RCCC13826_2075 CATGAGCCAGCTCAATCAAC – This study
Human interleukin 8 gene
(NM_000584)
hIL-8f TTTTGCCAAGGAGTGCTAAAGA 194 PB
b
hIL-8r AACCCTCTGCACCCAGTTTTC – PB
b
Human C1orf33 gene
(NM_016183)
hC1orf33f TCCAAGCGCGACAAGAAAGT 102 PB
b
hC1orf33r GTAGGTGTCCACACATTTCCG – PB
b
C. jejuni CDT B gene
(U51121)
P5 GAATCCGTTGGCACTTGGAATTTGCAAGGC 495 [40]
P6 GGATTCGTTAAAATCCCCTGCTATCATCCA – [40]
aGenBank or NCBI protein accession number indicated in brackets.
bPrimers sequences were obtained from the PrimerBank database http://pga.mgh.harvard.edu/primerbank/index.html.
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Permeability was assayed as described previously [25].
Briefly, monolayers were washed with Ringer’ss o l u t i o n ,
and a 3 kDa FITC-dextran probe (500 μl, 100 mM in
Ringer’s solution; Molecular Probes, Eugene, OR) was
added to the apical compartment and 1 ml of Ringer’s
solution was also added to the basal compartment. Fol-
lowing incubation for 3 h at 37°C, samples were col-
lected from the basal compartment and absorbance at
485 nm was measured.
Hemolysis
Hemolysis of sheep erythrocytes was measured as pre-
viously described [20]. In brief, C. concisus cells cultured
in Columbia broth as described above were centrifuged
(8000 × g, 3 min) and cell pellets were washed with ster-
ile PBS, suspended in PBS to 1 × 10
9 CFU/ml, and then
serially diluted 2-fold in PBS. Equal volumes (100 μl) of
cell suspension and sheep erythrocytes (2% vol/vol in
PBS) were mixed in a U-bottom 96-well plate. The plate
was then incubated at 37°C under microaerobic condi-
tions for 18 h. A comparative negative control (without
bacteria) was also incubated under similar conditions. A
positive control for total hemolysis (100%) was performed
by replacing the same volume of bacterial cell suspension
with distilled water. After incubation, the tubes were cen-
trifuged at 1000 × g for 5 min, and the OD490 of the
supernatants for the 1/3 dilution were measured. Data
were reported as the percent total hemolysis of sheep
erythrocytes (compared to the positive control).
DNA fragmentation, cytotoxicity, and metabolic activity
T84 monolayers were grown in 24-well plates and
inoculated as described above. Control monolayers were
also treated with camptothecin (4 μM), hydrogen perox-
ide (H2O2, 0.5 mM), or sterile broth. Following incuba-
tion, DNA fragmentation was measured using a Cellular
DNA Fragmentation ELISA kit (Roche Applied Science,
Laval, QC) according to the manufacturer’sp r o t o c o l .
Lactate dehydrogenase released into the surrounding tis-
sue culture was measured using a Cytotoxicity Detection
kit (Roche) according to the manufacturer’sp r o t o c o l .
Metabolic activity (i.e. MTT assay) was measured using
a Cell Proliferation Kit I (Roche) according to the man-
ufacturer’s protocol, except that gentamicin (500 μg/ml)
was incorporated into the MTT solution.
Interleukin-8 real-time quantitative PCR
T84 monolayers were grown in six-well plates and inocu-
lated with C. concisus and C. jejuni as described above. In
addition, monolayers were inoculated at an MOI of 100
with E. coli HB101. Following incubation, the culture
medium was removed and replaced with RNAlater (3 ml/
well; Qiagen), and cells were stored at 4°C until processed
for RNA extraction (< 1 week). Total RNA was isolated
using the RNeasy mini kit (Qiagen), according to the
manufacturer’s protocol. RNA was reverse transcribed
using a QuantiTect reverse transcription kit (Qiagen)
according to the manufacturer’s protocol. PCR was con-
ducted using an Mx3005P Stratagene thermocycler (Stra-
tagene, Cedar Creek, TX). All PCR reactions were carried
out in 20 μl volumes and contained 1X QuantiTect SYBR
Green PCR Master Mix (Qiagen), forward and reversed
primers (0.5 μM each; Table 5) and 2 μLo fR Tr e a c t i o n .
Amplification conditions were 1 cycle at 95°C for 15 min
followed by 40 cycles of 94°C for 15 s, 60°C for 30 s, and
72°C for 30 s. Melting curve analysis was conducted over
a range of 55 to 95°C to assess specificity of amplification.
Interleukin-8 expression was normalized to the house-
keeper gene, C1orf33, and fold changes in expression
relative to the sterile-broth control was calculated using
the 2
-ΔΔCT method.
Statistical analysis
Experiments were conducted at least three times on
separate occasions (i.e., replicates). Each assay was con-
ducted at least in duplicate (i.e., observations), and the
mean value was used for analysis. Data are expressed as
mean ± SEM. All statistical calculations were performed
with GraphPad InStat v.3.06 software (GraphPad Soft-
ware Inc., San Diego, CA). Data with three or more
treatments were compared by one way analysis of var-
iance, followed by the protected Tukey-Kramer multiple
comparison test. Data with two treatments were com-
pared using an unpaired Student’s t-test. Regression
analysis was performed using Pearson correlation analy-
sis. Statistical significance was established at P < 0.05.
Additional material
Additional file 1: Dendrogram of C. concisus AFLP profiles
demonstrating reproducibility between duplicate independently-
prepared samples. AFLP profiles were derived using the unweighted-
pair group average linkage of Pearson-product-moment correlation
coefficients from 22 Campylobacter concisus fecal isolates (designated
CHRB) and the type strain (LMG7788). The bar indicates percentage
similarity. *, isolates for which only a single profile was analyzed.
Additional file 1 contains a figure.
Additional file 2: Transepithelial resistance (TER) and FITC-dextran
permeability for confluent, polarized T84 monolayers inoculated
with Campylobacter concisus isolates
a. Additional file 2 contains a
table.
Additional file 3: PCR screening of genes coding for cytolethal
distending toxin (CDT), zonula occludens toxin (Zot), and S-layer
RTX for Campylobacter concisus isolates. Additional file 3 contains a
table.
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